title: Utility approach to decision-making in extended T1 and limited T2 glottic carcinoma.
abstract: It is still undecided if endoscopic laser surgery or radiotherapy is the preferable treatment in extended T1 and limited T2 glottic tumors. Health utilities assessed from patients can aid in decision-making.
  
  
  
  Patients treated for extended T1 or limited T2 glottic carcinoma by laser surgery (n = 12) or radiotherapy (n = 14) assigned health utilities using a visual analog scale (VAS), time tradeoff (TTO) technique and scored their voice handicap using the Voice Handicap Index (VHI).
  
  
  
  VAS and TTO scores were slightly lower for the laser group compared to the radiotherapy group, however, not significantly so. The VHI showed a correlation with the VAS score, which was very low in both groups and can be considered (near) normal.
  
  
  
  Patients show no clear preference for the outcomes of laser surgery or radiotherapy from a quality of life (QOL) or voice handicap point of view. These data can now be incorporated into decision-making models. © 2017 Wiley Periodicals, Inc. Head Neck, 2017 © 2016 Wiley Periodicals, Inc. Head Neck 39: 779-785, 2017.
authors.affiliation: Department of Ear, Nose, and Throat, Head and Neck Surgery, Leiden University Medical Center, Leiden, The Netherlands.
authors.forename: Yda
authors.initials: Y
authors.lastname: van Loon
authors.affiliation: Department of Medical Decision Making, Leiden University Medical Center, Leiden, The Netherlands.
authors.forename: Anne M
authors.initials: AM
authors.lastname: Stiggelbout
authors.affiliation: Department of Otorhinolaryngology, Head and Neck Surgery, Erasmus Medical Center, Rotterdam, The Netherlands.
authors.forename: Marieke M
authors.initials: MM
authors.lastname: Hakkesteegt
authors.affiliation: Department of Ear, Nose, and Throat, Head and Neck Surgery, Leiden University Medical Center, Leiden, The Netherlands.
authors.forename: Ton P M
authors.initials: TP
authors.lastname: Langeveld
authors.affiliation: Department of Otorhinolaryngology, Head and Neck Surgery, Erasmus Medical Center, Rotterdam, The Netherlands.
authors.forename: Rob J
authors.identifier: 0000-0001-7236-264X
authors.initials: RJ
authors.lastname: Baatenburg de Jong
authors.affiliation: Department of Ear, Nose, and Throat, Head and Neck Surgery, Leiden University Medical Center, Leiden, The Netherlands.
authors.forename: Elisabeth V
authors.initials: EV
authors.lastname: Sjögren
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D016022:Case-Control Studies; D000066491:Clinical Decision-Making / Q000379:methods*; D005260:Female; D005500:Follow-Up Studies; D005931:Glottis / Q000473:pathology* / Q000601:surgery; D006801:Humans; D007822:Laryngeal Neoplasms / Q000473:pathology* / Q000532:radiotherapy / Q000601:surgery*; D053685:Laser Therapy / Q000379:methods*; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness / Q000473:pathology; D009367:Neoplasm Staging; D009426:Netherlands; D010147:Pain Measurement; D057240:Patient Preference / Q000706:statistics & numerical data*; D017060:Patient Satisfaction / Q000706:statistics & numerical data; D011788:Quality of Life; D012189:Retrospective Studies; D018570:Risk Assessment; D013997:Time Factors; D016896:Treatment Outcome; D014833:Voice Quality
keywords: decision making; glottic cancer; laser surgery; radiotherapy; utility